News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Flynn James E
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/23/2023 |
SC 13D/A
| Flynn James E reports a 4.9% stake in CalciMedica, Inc. |
| 03/28/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 03/27/2023 |
SC 13D/A
| Flynn James E reports a 24.5% stake in CalciMedica, Inc. |
| 12/21/2022 |
SC 13D/A
| Flynn James E reports a 11.6% stake in Oncorus, Inc. |
| 11/23/2022 |
SC 13D/A
| Flynn James E reports a 24.5% stake in Graybug Vision, Inc. |
| 09/16/2022 |
SC 13D/A
| Flynn James E reports a 42.4% stake in Larimar Therapeutics, Inc. |
| 07/05/2022 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 04/27/2022 |
SC 13D/A
| Flynn James E reports a 9.4% stake in Acutus Medical, Inc. |
| 11/19/2021 |
SC 13D/A
| Flynn James E reports a 4.9% stake in DFP Healthcare Acquisitions Corp. |
| 08/26/2021 |
SC 13D/A
| Flynn James E reports a 9.5% stake in Acutus Medical, Inc. |
| 07/21/2021 |
SC 13D/A
| Flynn James E reports a 17.2% stake in Acutus Medical, Inc. |
| 07/13/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 07/02/2021 |
SC 13D/A
| Flynn James E reports a 32.9% stake in Larimar Therapeutics, Inc. |
| 07/01/2021 |
SC 13D/A
| Flynn James E reports a 36.4% stake in DFP Healthcare Acquisitions Corp. |
| 06/14/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/26/2021 |
SC 13D/A
| Flynn James E reports a 33.5% stake in Larimar Therapeutics, Inc. |
| 05/21/2021 |
SC 13D/A
| Flynn James E reports a 33.5% stake in Larimar Therapeutics, Inc. |
| 02/22/2021 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 01/08/2021 |
SC 13D/A
| Flynn James E reports a 0% stake in Protara Therapeutics, Inc. |
| 11/20/2020 |
SC 13D/A
| Flynn James E reports a 25.2% stake in Graybug Vision, Inc. |
| 07/01/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 06/25/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/26/2020 |
SC 13D/A
| Flynn James E reports a 37.9% stake in AdaptHealth Corp. |
| 05/05/2020 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 05/01/2020 |
SC 13D/A
| Flynn James E reports a 5% stake in Homology Medicines, Inc. |
| 04/20/2020 |
SC 13D/A
| Flynn James E reports a 7.1% stake in Homology Medicines, Inc. |
| 03/30/2020 |
SC 13D/A
| Flynn James E reports a 40.2% stake in AdaptHealth Corp. |
| 01/31/2020 |
SC 13D/A
| Flynn James E reports a 9.3% stake in Homology Medicines, Inc. |
| 01/24/2020 |
SC 13D/A
| Flynn James E reports a 42.7% stake in AdaptHealth Corp. |
| 01/17/2020 |
SC 13D/A
| Flynn James E reports a 7.4% stake in ArTara Therapeutics, Inc. |
| 12/30/2019 |
SC 13D/A
| Flynn James E reports a 11.9% stake in Homology Medicines, Inc. |
| 11/15/2019 |
SC 13D/A
| Flynn James E reports a 50.4% stake in AdaptHealth Corp. |
| 11/13/2019 |
SC 13D/A
| Flynn James E reports a 10% stake in Proteon Therapeutics, Inc. |
| 11/08/2019 |
SC 13D/A
| Flynn James E reports a 10% stake in Proteon Therapeutics, Inc. |
|
|
|